0001209191-23-011457.txt : 20230221
0001209191-23-011457.hdr.sgml : 20230221
20230221202154
ACCESSION NUMBER: 0001209191-23-011457
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230216
FILED AS OF DATE: 20230221
DATE AS OF CHANGE: 20230221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHELLER RICHARD H
CENTRAL INDEX KEY: 0001214133
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38959
FILM NUMBER: 23650243
MAIL ADDRESS:
STREET 1: C/O GENENTECH INC
STREET 2: 1 DNA WAY MS 49
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080-4990
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BridgeBio Pharma, Inc.
CENTRAL INDEX KEY: 0001743881
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3160 PORTER DR.
STREET 2: SUITE 250
CITY: PALO ALTO
STATE: CA
ZIP: 94304
BUSINESS PHONE: (650) 391-9740
MAIL ADDRESS:
STREET 1: 3160 PORTER DR.
STREET 2: SUITE 250
CITY: PALO ALTO
STATE: CA
ZIP: 94304
FORMER COMPANY:
FORMER CONFORMED NAME: BridgeBio Pharma LLC
DATE OF NAME CHANGE: 20180618
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-16
1
0001743881
BridgeBio Pharma, Inc.
BBIO
0001214133
SCHELLER RICHARD H
C/O BRIDGEBIO PHARMA, INC.
3160 PORTER DR., SUITE 250
PALO ALTO
CA
94304
1
0
0
0
Common Stock
2023-02-16
4
M
0
3196
A
55126
D
Common Stock
2023-02-16
4
F
0
1304
12.64
D
53822
D
Restricted Stock Units
2023-02-16
4
M
0
3196
0.00
D
Common Stock
3196
12783
D
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 3,196 shares of Common Stock underlying the Reporting Person's RSUs.
The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date.
/s/ Brian C. Stephenson, Attorney-in-Fact
2023-02-21